Alejandra L. G.
- Country
- Spain
- Department
- Parc Sanitari Sant Joan de Deu (#1)
Research Overview
- Long-term Safety and Tolerability Evaluation of Itepekimab in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease
- A Phase 2b, Multicenter, Randomized, Double-blind, Parallel group, Placebo-controlled, Dose Range Finding Study to Evaluate the Efficacy, Safety, and Tolerability of Nebulized CSL787 in Adults (18 to 85 years) with Non-cystic Fibrosis Bronchiectasis
Data & Insights
Has run more than one trial at 12 of 141 partner sites.
Specializations
Respiratory Medicine
The investigator specializes in treating Chronic Obstructive Pulmonary Disease (COPD), with particular focus on innovative therapeutic approaches for patients with moderate to severe conditions.
- COPD Management
- Long-term Treatment Evaluation
- Respiratory Disease Assessment
Clinical expertise extends to evaluating novel therapeutic agents for respiratory conditions and their long-term safety profiles.
Therapeutic Development
Active involvement in assessing biological therapies for respiratory conditions, with specific interest in evaluating treatment tolerability in chronic respiratory disorders.
- Novel Therapeutic Assessment
- Safety Monitoring
- Treatment Tolerability Studies
Focuses on investigating extended duration therapeutic interventions for chronic respiratory conditions.
Clinical Assessment
Expertise in conducting long-term clinical evaluations of respiratory medications, particularly in patients with established COPD diagnoses.
- Patient Safety Assessment
- Extended Duration Studies
- Clinical Monitoring
Specialized in evaluating treatment outcomes in participants with varying degrees of respiratory impairment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.